• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    China Central Venous Catheter Market

    ID: MRFR/MED/50718-HCR
    200 Pages
    Rahul Gotadki
    October 2025

    China Central Venous Catheter Market Research Report By Product Type (Non-tunneled Catheters, Tunneled Catheters), By Property (Non-Antimicrobial Catheters, Antimicrobial Catheters, Others), By Design (Multi Lumen, Double Lumen, Single Lumen) and By Composition (Polyurethane, Silicone, Others)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    China Central Venous Catheter Market Infographic
    Purchase Options

    China Central Venous Catheter Market Summary

    The China Central Venous Catheter market is projected to grow from 134 million USD in 2024 to 244 million USD by 2035, reflecting a robust growth trajectory.

    Key Market Trends & Highlights

    China Central Venous Catheter Key Trends and Highlights

    • The market is expected to expand at a compound annual growth rate (CAGR) of 5.6% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 244 million USD, indicating substantial growth opportunities.
    • In 2024, the market is valued at 134 million USD, laying a solid foundation for future expansion.
    • Growing adoption of advanced medical technologies due to increasing healthcare investments is a major market driver.

    Market Size & Forecast

    2024 Market Size 134 (USD Million)
    2035 Market Size 244 (USD Million)
    CAGR (2025-2035) 5.6%

    Major Players

    C. R. Bard, Halyard Health, Boston Scientific, Vygon, AngioDynamics, Fresenius Kabi, Teleflex, B.Braun, Nipro Corporation, Cook Medical, Pfizer, Medtronic, Surmodics, Terumo, Smiths Medical

    China Central Venous Catheter Market Trends

    The China Central Venous Catheter Market is currently experiencing several significant trends that reflect the evolving healthcare landscape in the country. A key market driver is the increasing incidence of chronic diseases, such as cardiovascular disorders and cancer, which require long-term intravenous therapy. Furthermore, the rising elderly population in China is leading to a higher demand for central venous catheters, as older adults are generally more susceptible to health complications that necessitate such medical devices. 

    Additionally, the robust expansion of healthcare infrastructure and facilities, along with government investments aimed at improving medical services, bolster the growth of this market.This segment also offers a plethora of opportunities for exploration. Healthcare providers are exploring new opportunities to improve patient care and outcomes through the implementation of central venous catheters, which is facilitated by the growth of telemedicine and remote patient monitoring. Manufacturers have the opportunity to capitalise on the demand for sophisticated medical solutions by developing catheters that are safer, more durable, and patient-friendly as a result of advancements in material science. 

    A growing emphasis on safety and infection control has been demonstrated by recent trends. The Chinese government and health authorities are advocating the adoption of advanced design features and antimicrobial coatings in order to address the risks associated with catheter-related bloodstream infections. Moreover, the growing consciousness regarding patient safety is resulting in more stringent regulations and guidelines that manufacturers are obligated to comply with, which in turn is driving quality enhancements in the products that are currently available in the market.

    The China Central Venous Catheter Market is being guided towards a future that prioritises patient outcomes and healthcare efficiency by the synergy between technological advancements and regulatory support.

      

    Market Segment Insights

    Central Venous Catheter Market Product Type Insights

    The China Central Venous Catheter Market is characterized by its diverse product types, most notably Non-tunneled Catheters and Tunneled Catheters, both of which play a crucial role in medical procedures requiring long-term vascular access. Non-tunneled Catheters are often utilized for short-duration treatments, such as hemodialysis, where quick and easy access to the bloodstream is essential. 

    Their design allows for immediate insertion and retrieval, making them particularly valuable in emergency and acute care settings where time is critical. In contrast, Tunneled Catheters are favored for long-term access, generally used for ongoing treatments like chemotherapy or total parenteral nutrition. They are designed to remain in place for weeks or even months, providing a stable access point while reducing the risks of infection associated with repeated access.

    The significance of these product types is underscored by the growing prevalence of chronic diseases in China, which necessitates reliable and effective vascular access solutions. Factors such as an aging population and increased rates of conditions requiring long-term infusion therapies contribute to the heightened demand for both Non-tunneled and Tunneled Catheters. 

    Moreover, advancements in catheter technology and materials are continually improving patient outcomes and safety, making these devices integral to healthcare practices in the country. The China Central Venous Catheter Market is also shaped by regulatory oversight and quality demand, requiring manufacturers to innovate continuously and meet the challenges posed by infection control and patient safety. With a focus on quality and accessibility, the dynamics within this market segment highlight the importance of Non-tunneled and Tunneled Catheters in supporting China’s healthcare infrastructure.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Central Venous Catheter Market Property Insights

    The China Central Venous Catheter Market under the Property segment reflects a robust growth trajectory influenced by various healthcare factors. Technological advancements and improved healthcare infrastructure in China have significantly contributed to the market's development. Non-Antimicrobial Catheters, while often chosen for their cost-effectiveness, are pivotal in routine procedures but are challenged by infection risks. In contrast, Antimicrobial Catheters have gained popularity due to their ability to reduce infection rates, making them crucial in critical care settings, especially amid rising awareness of hospital-acquired infections.

    The Others category captures a range of specialized catheters, which are designed for specific patient needs, thereby expanding treatment options and enhancing overall patient care. The growing demand for quality healthcare services in China is a driving force for these segments, as healthcare providers prioritize both patient safety and effective treatment modalities in their clinical practices. With the increasing prevalence of chronic diseases and a larger aging population in China, these catheter market dynamics are expected to continue evolving, offering opportunities for innovation and expansion within these segments.

    Central Venous Catheter Market Design Insights

    The Design segment of the China Central Venous Catheter Market presents a diverse range of products, with various catheter designs such as Multi Lumen, Double Lumen, and Single Lumen playing crucial roles in enhancing patient care. Multi Lumen catheters provide the versatility needed for simultaneous administration of multiple therapies, making them essential in critical care settings where multiple treatments are required. Double Lumen catheters are significant for efficiently managing fluid administration and blood sampling, thus becoming a preferred choice in oncology and intensive care.

    Single Lumen designs, being straightforward in application, cater to a broad range of patients and scenarios, often facilitating easier insertion and reduced complications. The growing demand for advanced catheter designs in China is driven by an increase in chronic diseases and the emphasis on improved healthcare outcomes. Rising efforts by healthcare providers to integrate innovative solutions into treatment protocols further reinforce the relevance of these designs within the overall China Central Venous Catheter Market. As hospitals and medical facilities evolve, understanding the nuances of the various catheter designs becomes pivotal for supporting patient management strategies effectively.

    Central Venous Catheter Market Composition Insights

    The China Central Venous Catheter Market showcases a diverse Composition segment that significantly influences the healthcare landscape. Within this segment, Polyurethane and Silicone materials play a pivotal role, addressing critical needs for biocompatibility and durability in clinical settings. Polyurethane is often favored for its flexibility and resistance to kinking, making it ideal for patients requiring long-term catheter use. In contrast, Silicone is known for its softness and reduced friction against blood vessels, minimizing irritation.These characteristics lead to enhanced patient comfort and a decrease in complications, reflecting the growing demands for high-quality medical devices in China. 

    Additionally, other materials are also employed to cater to various clinical requirements, thus ensuring a comprehensive approach to patient care. As the healthcare industry evolves, the focus on innovative materials in the China Central Venous Catheter Market underscores a trend toward improved patient outcomes and heightened safety standards in medical treatment. The ongoing developments in material science present opportunities for manufacturers to create advanced solutions tailored to the unique challenges faced in vascular access procedures.

    Get more detailed insights about China Central Venous Catheter Market Research Report- Forecast To 2035

    Key Players and Competitive Insights

    The China Central Venous Catheter Market is an integral part of the country's healthcare system, characterized by its rapid growth and increasing investments in medical technology. The competitive landscape of this market is shaped by various domestic and international players vying for market share. Key factors influencing competition include product innovation, pricing strategies, distribution networks, and regulatory compliance. The increasing prevalence of chronic diseases and the rising demand for outpatient and minimally invasive surgical procedures have further intensified competition among manufacturers. 

    This dynamic environment encourages companies to develop advanced catheters that meet evolving clinical needs, thereby improving patient outcomes and driving market expansion.C. R. Bard has established a strong presence in the China Central Venous Catheter Market, reflecting its commitment to delivering quality healthcare solutions. The company is recognized for its extensive portfolio of medical devices, notably its innovative catheter designs that enhance patient safety and ease of use. C. R. Bard's strengths in this market include its reputation for reliability and effectiveness, supported by robust research and development efforts. 

    The company's strategic partnerships with healthcare providers facilitate the distribution of its products across various regions in China, ensuring accessibility for healthcare facilities. Furthermore, C. R. Bard's continued investment in localized manufacturing and product customization allows for responsiveness to the specific needs of the Chinese market, thus solidifying its competitive advantage.Halyard Health is also a significant player in the China Central Venous Catheter Market, focusing on delivering high-performance medical solutions tailored to the local healthcare landscape. The company offers a range of key products, including various types of central venous catheters designed to meet diverse clinical requirements. 

    Halyard Health’s strengths lie in its commitment to innovation, showcased through advanced technology that enhances catheter functionality and minimizes complications. The company has actively expanded its market presence in China through strategic partnerships and collaborations that enhance its distribution capabilities. Halyard Health has made strides in mergers and acquisitions, allowing for the integration of complementary technologies and reinforcing its position in the market. This strategic approach helps Halyard Health to strengthen its product offerings and cater to the growing demands of healthcare providers and patients alike within China.

    Key Companies in the China Central Venous Catheter Market market include

    Industry Developments

    In recent months, the China Central Venous Catheter Market has seen significant developments, including notable growth in market valuation driven by increasing healthcare expenditure and advancements in medical technologies. Companies such as C. R. Bard and Teleflex have expanded their product portfolios, focusing on innovative catheter designs that enhance patient safety and ease of use. 

    Moreover, there has been a rising demand for these medical devices due to the country's aging population and the prevalence of chronic diseases. In terms of mergers and acquisitions, Halyard Health has been actively pursuing strategic partnerships to strengthen its market presence, while Fresenius Kabi remains focused on enhancing its research capabilities in catheter technology. 

    Additionally, government policies have supported the expansion of healthcare infrastructure, fostering an environment conducive to growth in this market segment. Over the last two years, market players like Boston Scientific have reported increased sales, indicating positive trends and greater adoption of central venous catheters in hospitals and healthcare facilities across China.

    Market Segmentation

    Central Venous Catheter Market Design Outlook

    • Multi Lumen
    • Double Lumen
    • Single Lumen

    Central Venous Catheter Market Property Outlook

    • Non-Antimicrobial Catheters
    • Antimicrobial Catheters
    • Others

    Central Venous Catheter Market Composition Outlook

    • Polyurethane Silicone Others
    • Polyurethane
    • Silicone
    • Others

    Central Venous Catheter Market Product Type Outlook

    • Non-tunneled Catheters
    • Tunneled Catheters

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 126.89(USD Million)
    MARKET SIZE 2024 134.0(USD Million)
    MARKET SIZE 2035 244.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 5.6% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED C. R. Bard, Halyard Health, Boston Scientific, Vygon, AngioDynamics, Fresenius Kabi, Teleflex, B.Braun, Nipro Corporation, Cook Medical, Pfizer, Medtronic, Surmodics, Terumo, Smiths Medical
    SEGMENTS COVERED Product Type, Property, Design, Composition
    KEY MARKET OPPORTUNITIES Growing demand for minimally invasive procedures, Increasing prevalence of chronic diseases, Expanding geriatric population requiring care, Advancements in catheter technologies, Rise in healthcare expenditure and infrastructure
    KEY MARKET DYNAMICS growing aging population, increasing chronic diseases, rising healthcare expenditure, advancements in catheter technology, demand for minimally invasive procedures
    COUNTRIES COVERED China

    FAQs

    What is the expected market size of the China Central Venous Catheter Market in 2024?

    The market is anticipated to be valued at 134.0 million USD in 2024.

    What is the projected market value of the China Central Venous Catheter Market by 2035?

    By 2035, the market is expected to reach a value of 244.0 million USD.

    What is the expected CAGR for the China Central Venous Catheter Market from 2025 to 2035?

    The market is projected to grow at a CAGR of 5.6% during the forecast period from 2025 to 2035.

    What are the anticipated values for Non-tunneled Catheters in the market by 2035?

    The value for Non-tunneled Catheters is expected to increase to 110.0 million USD by 2035.

    What will be the market value of Tunneled Catheters in 2024?

    In 2024, the market value of Tunneled Catheters is expected to be 74.0 million USD.

    Who are the major players in the China Central Venous Catheter Market?

    Key players in the market include C. R. Bard, Halyard Health, Boston Scientific, and Teleflex among others.

    What is the expected market growth rate for Non-tunneled Catheters from 2025 to 2035?

    The growth rate for Non-tunneled Catheters is expected to align with the overall market CAGR of 5.6% from 2025 to 2035.

    What growth opportunities exist within the China Central Venous Catheter Market?

    Emerging trends and rising demand for advanced medical devices present significant growth opportunities in the market.

    How do current global conflicts affect the China Central Venous Catheter Market?

    Current global conflicts may impact supply chains and production costs, potentially influencing market prices.

    What will the market size for Tunneled Catheters be by 2035?

    The market size for Tunneled Catheters is projected to grow to 134.0 million USD by 2035.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials